Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06835959 · ClinicalTrials.gov registry record · NA
Moms@Home: A Storytelling-based Mobile Health Intervention to Improve Blood Pressure Management in Pregnancy
A NA study of Gestational Hypertension and Hypertension in Pregnancy, sponsored by University of Massachusetts, Worcester.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06835959: Recruiting NA study of Gestational Hypertension and Hypertension in Pregnancy, sponsored by University of Massachusetts, Worcester.
NCT06835959 is a NA study of Gestational Hypertension and Hypertension in Pregnancy that is actively recruiting participants, run by University of Massachusetts, Worcester. The registered enrollment target is 100 participants, below the 1,352-participant average among 18 other Gestational Hypertension trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06835959, a NA study of Gestational Hypertension and Hypertension in Pregnancy, is actively recruiting participants, sponsored by University of Massachusetts, Worcester.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot study will examine the effects of a digital health approach, Moms@Home, on home blood pressure monitoring in a diverse population of pregnant women with hypertension.
Primary Outcome
Home blood pressure monitoring (HBPM) adherence is defined as performing HBPM measures ≥3 out of 7 days/week
Conditions Studied
Interventions
- BEHAVIORAL Moms@Home
- BEHAVIORAL Enhanced Standard of Care
Study Locations (1)
Massachusetts
- UMass Memorial Medical Center - Memorial Campus - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-05-16 |
| Est. Completion | 2027-11-16 |
| Phase | NA |
What NCT06835959 shows while recruiting
NCT06835959 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,352-participant average among 18 other Gestational Hypertension trials with a reported enrollment target (93% lower).
The record links to 3 conditions, with Gestational Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Moms@Home is the first listed.
NCT06835959 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06835959 about?
NCT06835959 is a clinical study titled "Moms@Home: A Storytelling-based Mobile Health Intervention to Improve Blood Pressure Management in Pregnancy". This pilot study will examine the effects of a digital health approach, Moms@Home, on home blood pressure monitoring in a diverse population of pregnant women with hypertension.
What is the current status of trial NCT06835959?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-05-16. Estimated completion is 2027-11-16.
What conditions does trial NCT06835959 study?
This clinical trial studies the following conditions: Gestational Hypertension, Hypertension in Pregnancy, Chronic Hypertension.
What interventions are being tested in trial NCT06835959?
The interventions under investigation include: Moms@Home (BEHAVIORAL), Enhanced Standard of Care (BEHAVIORAL).
Who is sponsoring clinical trial NCT06835959?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06835959 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06835959's enrollment target sits among peer trials
100 14th of 18 higher than 4 of 18 other Gestational Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gestational Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Delivering HOPE (Helping Women Optimize Prenatal Equity)
RECRUITING · NA
-
Evaluating the Effectiveness of a Food is Medicine Community Health Worker Program for Pregnant Women
RECRUITING · NA
-
The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.
RECRUITING · NA
-
Preventing Obstetric Complications With Dietary Intervention
RECRUITING · NA
-
Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education
RECRUITING · NA
-
Mobile Health Interventions to Prevent Heart Disease After Hypertensive Disorders of Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI